{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:17:55Z","timestamp":1773011875184,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07332-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:05:27Z","timestamp":1751360727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protective antibodies against diphtheria, tetanus, and pertussis following revaccination in children and young adults having undergone haematopoietic stem cell transplantation"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2624-6398","authenticated-orcid":false,"given":"Ravipreeya Sukswadi Na","family":"Ayudhya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2904-0181","authenticated-orcid":false,"given":"Chanya","family":"Pongpatipat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-7471","authenticated-orcid":false,"given":"Usanarat","family":"Anurathapan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8118-163X","authenticated-orcid":false,"given":"Samart","family":"Pakakasama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7376-9393","authenticated-orcid":false,"given":"Suradej","family":"Hongeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-3032","authenticated-orcid":false,"given":"Chompunuch","family":"Klinmalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1833-5127","authenticated-orcid":false,"given":"Nopporn","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"17","key":"7332_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813\u201326.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"7332_CR2","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1038\/bmt.2008.289","volume":"42","author":"J Styczynski","year":"2008","unstructured":"Styczynski J, Gil L, Party EPDW. Prevention of infectious complications in pediatric HSCT. Bone Marrow Transpl. 2008;42(Suppl 2):S77\u201381.","journal-title":"Bone Marrow Transpl"},{"key":"7332_CR3","unstructured":"Government of Canada. Immunization of immunocompromised persons: Canadian Immunization Guide 2018 [updated. March 2023. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-3-vaccination-specific-populations\/page-8-immunization-immunocompromised-persons.html"},{"issue":"2","key":"7332_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.idc.2019.02.007","volume":"33","author":"M Kamboj","year":"2019","unstructured":"Kamboj M, Shah MK. Vaccination of the stem cell transplant recipient and the hematologic malignancy patient. Infect Dis Clin North Am. 2019;33(2):593\u2013609.","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"7332_CR5","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/j.bbmt.2019.10.030","volume":"26","author":"A Majeed","year":"2020","unstructured":"Majeed A, Harris Z, Brucks E, Hinchman A, Farooqui AA, Tariq MJ, et al. Revisiting role of vaccinations in donors, transplant recipients, immunocompromised hosts, travelers, and household contacts of stem cell transplant recipients. Biol Blood Marrow Transpl. 2020;26(2):e38\u201350.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"7332_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309\u201318.","journal-title":"Clin Infect Dis"},{"key":"7332_CR7","unstructured":"Centers for Disease Control and Prevention. Tdap (Tetanus, Diphtheria, Pertussis) Vaccine information statement 2021 [Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/tdap.html"},{"issue":"3","key":"7332_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1128\/CVI.00682-14","volume":"22","author":"J Embree","year":"2015","unstructured":"Embree J, Law B, Voloshen T, Tomovici A. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart. Clin Vaccine Immunol. 2015;22(3):282\u201390.","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"7332_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4161\/hv.7.5.14982","volume":"7","author":"V Gajdos","year":"2011","unstructured":"Gajdos V, Soubeyrand B, Vidor E, Richard P, Boyer J, Sadorge C, et al. Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS ((R))) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT polio ((R))) given as a booster dose at 6 years of age. Hum Vaccin. 2011;7(5):549\u201356.","journal-title":"Hum Vaccin"},{"issue":"49","key":"7332_CR10","doi-asserted-by":"publisher","first-page":"e5571","DOI":"10.1097\/MD.0000000000005571","volume":"95","author":"E Gowin","year":"2016","unstructured":"Gowin E, Wysocki J, Ka\u0142u\u017cna E, \u015awi\u0105tek-Ko\u015bcielna B, Wysocka-Leszczy\u0144ska J, Michalak M, et al. Does vaccination ensure protection? Assessing diphtheria and tetanus antibody levels in a population of healthy children: A cross-sectional study. Medicine. 2016;95(49):e5571.","journal-title":"Medicine"},{"issue":"32","key":"7332_CR11","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1016\/j.vaccine.2011.05.046","volume":"29","author":"M Paulke-Korinek","year":"2011","unstructured":"Paulke-Korinek M, Fischmeister G, Grac A, Rendi-Wagner P, Kundi M, Mohsenzadeh-Rabbani A, et al. Persistence of antibodies in 4\u20138 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV\/Hib and MMR vaccines. Vaccine. 2011;29(32):5130\u20136.","journal-title":"Vaccine"},{"issue":"17","key":"7332_CR12","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.vaccine.2018.03.029","volume":"36","author":"V Pool","year":"2018","unstructured":"Pool V, Tomovici A, Johnson DR, Greenberg DP, Decker MD. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA. Vaccine. 2018;36(17):2282\u20137.","journal-title":"Vaccine"},{"issue":"8","key":"7332_CR13","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00277-020-04072-9","volume":"99","author":"J Winkler","year":"2020","unstructured":"Winkler J, Tittlbach H, Schneider A, Buchstaller C, Mayr A, Vasova I, et al. Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation. Ann Hematol. 2020;99(8):1895\u2013906.","journal-title":"Ann Hematol"},{"issue":"45","key":"7332_CR14","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1016\/j.vaccine.2014.08.069","volume":"32","author":"A Aase","year":"2014","unstructured":"Aase A, Herstad TK, Jorgensen SB, Leegaard TM, Berbers G, Steinbakk M, et al. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7\u20138 years of age. Vaccine. 2014;32(45):5931\u20136.","journal-title":"Vaccine"},{"key":"7332_CR15","doi-asserted-by":"publisher","first-page":"100559","DOI":"10.1016\/j.ijregi.2024.100559","volume":"14","author":"PNT Nguyen","year":"2025","unstructured":"Nguyen PNT, Heininger U, Muloiwa R, von K\u00f6nig CHW, Hozbor D, Ong-Lim A, et al. Pertussis in Southeast asia: country-level burden and recommendations from the global pertussis initiative. IJID Reg. 2025;14:100559.","journal-title":"IJID Reg"},{"issue":"1","key":"7332_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2141.2011.08913.x","volume":"156","author":"H Inaba","year":"2012","unstructured":"Inaba H, Hartford CM, Pei D, Posner MJ, Yang J, Hayden RT, et al. Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic Haematopoietic stem cell transplantation. Br J Haematol. 2012;156(1):109\u201317.","journal-title":"Br J Haematol"},{"issue":"3 Pt 2","key":"7332_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1542\/peds.96.3.584","volume":"96","author":"C Christy","year":"1995","unstructured":"Christy C, Pichichero ME, Reed GF, Decker MD, Anderson EL, Rennels MB, et al. Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines. Pediatrics. 1995;96(3 Pt 2):584\u20137.","journal-title":"Pediatrics"},{"issue":"2","key":"7332_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.htct.2022.05.008","volume":"45","author":"AR Belinovski","year":"2023","unstructured":"Belinovski AR, Pelegrina PD, Lima ACM, Dumke CCK, Rodrigues AM, Loth G, et al. Immune reconstitution after allogenic stem cell transplantation: an observational study in pediatric patients. Hematol Transfus Cell Ther. 2023;45(2):235\u201344.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"7332_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ajh.21921","volume":"86","author":"YJ Chang","year":"2011","unstructured":"Chang YJ, Zhao XY, Huo MR, Xu LP, Liu DH, Liu KY, et al. Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies. Am J Hematol. 2011;86(2):227\u201330.","journal-title":"Am J Hematol"},{"issue":"10","key":"7332_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bmt.1705648","volume":"39","author":"C Heining","year":"2007","unstructured":"Heining C, Spyridonidis A, Bernhardt E, Schulte-Monting J, Behringer D, Grullich C, et al. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transpl. 2007;39(10):613\u201322.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"7332_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.transproceed.2014.11.042","volume":"47","author":"L Rigoni","year":"2015","unstructured":"Rigoni L, Scroferneker ML, Pitombeira BS, Ottoni E, Paz A, Fischer G, et al. Importance of early absolute lymphocyte count after allogeneic stem cell transplantation: a retrospective study. Transpl Proc. 2015;47(2):511\u20136.","journal-title":"Transpl Proc"},{"issue":"9","key":"7332_CR22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.bbmt.2008.06.012","volume":"14","author":"M Pao","year":"2008","unstructured":"Pao M, Papadopoulos EB, Chou J, Glenn H, Castro-Malaspina H, Jakubowski AA, et al. Response to Pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transpl. 2008;14(9):1022\u201330.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"7332_CR23","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/bmt.2017.87","volume":"52","author":"PDE Miller","year":"2017","unstructured":"Miller PDE, de Silva TI, Skinner R, Gilleece M, Peniket A, Hamblin A, et al. Routine vaccination practice after adult and paediatric allogeneic Haematopoietic stem cell transplant: a survey of UK NHS programmes. Bone Marrow Transpl. 2017;52(7):1082.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"7332_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2022.11.005","volume":"86","author":"P Miller","year":"2023","unstructured":"Miller P, Patel SR, Skinner R, Dignan F, Richter A, Jeffery K, et al. Joint consensus statement on the vaccination of adult and paediatric Haematopoietic stem cell transplant recipients: prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the children\u2019s cancer and leukaemia group (CCLG), and British infection association (BIA). J Infect. 2023;86(1):1\u20138.","journal-title":"J Infect"},{"issue":"16","key":"7332_CR25","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.vaccine.2011.02.018","volume":"29","author":"I Hilgendorf","year":"2011","unstructured":"Hilgendorf I, Freund M, Jilg W, Einsele H, Gea-Banacloche J, Greinix H, et al. Vaccination of allogeneic Haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. Vaccine. 2011;29(16):2825\u201333.","journal-title":"Vaccine"},{"issue":"20","key":"7332_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","volume":"16","author":"J Storsaeter","year":"1998","unstructured":"Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 1998;16(20):1907\u201316.","journal-title":"Vaccine"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07332-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07332-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07332-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:05:32Z","timestamp":1751360732000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07332-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7332"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07332-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work was approved by the Human Research Ethics Committee, Faculty of Medicine Ramathibodi Hospital, Mahidol University (approval number MURA 2021\/150) chaired by Dr. Chusak Okaschareon. Written informed consent was obtained from participants aged 18 years and older and participants\u2019 legally authorized representatives if participants aged\u2009<\u200918 years. Assent was obtained from participants aged 7\u201318 years old. The study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}